Home/Engrail Therapeutics/Joe Horrigan, MD

JH

Joe Horrigan, MD

Exec. VP, Clinical Development and Medical Affairs

Engrail Therapeutics

Therapeutic Areas

Neurologic Disorders Neuropsychiatric Disorders Neurodevelopmental Disorders

Leadership Team at Engrail Therapeutics

Vikram Sudarsan, PhD

President and Chief Executive Officer

Kimberly Vanover, PhD

Chief Scientific Officer

View full Engrail Therapeutics profile